| A Sampling of Highlights from the Literature: Article Recommendations from Our Deputy and Senior Editors | Cancer Immunology Research | 38 days | save |  |  |  |  |
| How to Reprogram Myeloma-Associated Macrophages: Target IKZF1 | Cancer Immunology Research | 38 days | save | | | | |
| Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy | Cancer Immunology Research | 38 days | save | | | | |
| At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer | Cancer Immunology Research | 38 days | save | | | | |
| The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages | Cancer Immunology Research | 38 days | save | | | | |
| Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin | Cancer Immunology Research | 38 days | save | | | | |
| ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity | Cancer Immunology Research | 38 days | save | | | | |
| IL1{beta} Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D | Cancer Immunology Research | 38 days | save | | | | |
| The Tumor Microenvironment Impairs Th1 IFN{gamma} Secretion through Alternative Splicing Modifications of Irf1 Pre-mRNA | Cancer Immunology Research | 38 days | save | | | | |
| A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer | Cancer Immunology Research | 38 days | save | | | | |
| Notch-Regulated Dendritic Cells Restrain Inflammation-Associated Colorectal Carcinogenesis | Cancer Immunology Research | 38 days | save | | | | |
| A Sampling of Highlights from the Literature: Article Recommendations from Our Deputy and Senior Editors | Cancer Immunology Research | 66 days | save | | | | |
| Mystery Checkpoint Revealed: KIR3DL3 Finally Found a Ligand in HHLA2 | Cancer Immunology Research | 66 days | save | | | | |
| About the Master | Cancer Immunology Research | 66 days | save | | | | |
| Health and Fitness at the Single-Cell Level | Cancer Immunology Research | 66 days | save | | | | |
| Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma | Cancer Immunology Research | 66 days | save | | | | |
| Kindlin3-Dependent CD11b/CD18-Integrin Activation Is Required for Potentiation of Neutrophil Cytotoxicity by CD47-SIRP{alpha} Checkpoint Disruption | Cancer Immunology Research | 66 days | save | | | | |
| KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1 | Cancer Immunology Research | 66 days | save | | | | |
| Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors | Cancer Immunology Research | 66 days | save | | | | |
| Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells | Cancer Immunology Research | 66 days | save | | | | |
| Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity | Cancer Immunology Research | 66 days | save | | | | |
| Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity | Cancer Immunology Research | 66 days | save | | | | |
| Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy | Cancer Immunology Research | 66 days | save | | | | |
| Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, Enable | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO001: Results from a preclinical study to evaluate the efficacy of polyvalent immunoglobulins on the imbalance of (anti-)inflammatory immune cell responses in clinical colorectal cancer | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR001: Cancer stem cells as origin of tumor associated immune cells | Cancer Immunology Research | 66 days | save | | | | |
| Abstract IA02: A case for priming, not checkpoint | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO002: APOBEC mutagenesis as a driver of tumor evolution by promoting tumor recurrence and modulating tumor-immune system interactions in a syngeneic murine model of breast cancer | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR002: Highly parallel knock-in targeting for genome engineering of cellular therapies | Cancer Immunology Research | 66 days | save | | | | |
| Abstract IA03: Engineering artificial antigen presenting cells, aAPC, for cancer immunotherapy: From bench to bedside | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO003: CD38 in the advanced prostate cancer | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR003: Single-cell profiling of acute myeloid leukemia (AML) and its microenvironment reveals a CD8 continuum and adaptable T cell plasticity in response to PD-1 blockade-based therapy | Cancer Immunology Research | 66 days | save | | | | |
| Abstract IA04: Targeting macrophages to promote anti-tumor immunity | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR004: Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation | Cancer Immunology Research | 66 days | save | | | | |
| Abstract IA05: Innate immune defenses against cancer: Potential for mobilizing NK cells for cancer immunotherapy | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO005: The overexpression of Immune oncology-related genes NFSF14, LY96, SLC11A1 and CTSL are associated with short survival in glioblastoma | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR005: Highly potent fully human anti-VISTA antibodies - A new target checkpoint inhibitor against immunosuppressive myeloid cells | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO006: Computational identification of female-biased breast cancer candidate genes correlated with tumor-infiltrating immune cell types | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR006: 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression | Cancer Immunology Research | 66 days | save | | | | |
| Abstract IA07: The QuEST for an effective immunotherapy for prostate cancer | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO007: Tumor-immune communication via extracellular vesicles | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR007: Is sex an effect modifier for cancer immune checkpoint inhibitors? - A population-based study | Cancer Immunology Research | 66 days | save | | | | |
| Abstract IA08: What are some different ways to evaluate immunotherapy combinations? | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO008: The mouse colon modulates human microbes in transplantable murine tumor models after human fecal microbiota transfer (FMT) | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR008: Armed Myxoma virus demonstrates therapeutic activity in pre-clinical xenograft models | Cancer Immunology Research | 66 days | save | | | | |
| Abstract IA09: The IRE1 ER stress sensor activates natural killer cell immunity by regulating c-Myc | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO009: Epigenetic silencing by SETDB1 represses tumor-cell intrinsic immunogenicity | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PR009: The functional genomic landscape of recurrent glioblastoma | Cancer Immunology Research | 66 days | save | | | | |
| Abstract IA10: Building improved personal cancer vaccines | Cancer Immunology Research | 66 days | save | | | | |
| Abstract PO010: The inhibition of IWS1 phosphorylation promotes genomic instability, the cGAS/STING pathway activation and PD-L1 levels, through the U2AF2 alternative RNA splicing and Sororin expression | Cancer Immunology Research | 66 days | save | | | | |
| | 
report | next » |
| |
